BioTalent Canada has launched its first 45 National Occupational Standards (NOS) for Canada’s bio-economy. These standards were validated by industry stakeholders and will replace BioTalent Canada’s Skills Profiles and Skills At-A-Glances…. Read More
WALTHAM, MASS. & DUBLIN– Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced that they have entered into a… Read More
Elecsys IGRA SARS-CoV-2 test supports the better understanding of immune response to SARS-CoV-2 infection or vaccination The test detects T-cell response, which may play an important role in determining if immune protection has… Read More
The trial, which is recruiting patients and cancer survivors, will evaluate the use of cannabis oils for cancer-related symptom management. The first- national clinical trial of medical cannabis oil extracts… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the appointment… Read More
